Joan E. Trey
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Carcinogens and Genotoxicity Assessment
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
-
- Carcinogens and Genotoxicity Assessment 2
-
- Head and Neck Cancer Studies 1
- Co-authors
- Stanton L. Gerson (4 shared papers)Kathleen M. Miller (3 shared papers)Nathan A. Berger (1 shared paper)Irving Kushner (1 shared paper)S L Gerson (1 shared paper)James K. V. Willson (1 shared paper)J R Haaga (1 shared paper)T A Stellato (1 shared paper)
- Journals
- Critical Reviews in Oncology/Hematology (1 paper)Cancer (1 paper)Journal of Clinical Oncology (1 paper)The Lancet Oncology (1 paper)Carcinogenesis (1 paper)
- Partner nations
- United States
In The Last Decade
Joan E. Trey
9 papers receiving 905 citations
Joan E. Trey's Hit Papers
Peers
Comparison fields: 5 of 76
- Cancer Research 280
- Oncology 419
- Genetics 109
- Hematology 65
- Molecular Biology 375
Countries citing papers authored by Joan E. Trey
This map shows the geographic impact of Joan E. Trey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan E. Trey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan E. Trey more than expected).
Fields of papers citing papers by Joan E. Trey
This network shows the impact of papers produced by Joan E. Trey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan E. Trey. The network helps show where Joan E. Trey may publish in the future.
Co-authors
The 12 scholars most cited alongside Joan E. Trey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 461 |
| 2 | 1986 | 260 | |
| 3 | 1995 | 65 | |
| 4 | Potentiation of nitrosourea cytotoxicity in human leukemic cells by inactivation of O6-alkylguanine-DNA alkyltransferase. | 1988 | 57 |
| 5 | Repair of O6-alkylguanine during DNA synthesis in murine bone marrow hematopoietic precursors. | 1987 | 28 |
| 6 | 1995 | 28 | |
| 7 | The role of O6-alkylguanine DNA alkyltransferase in limiting nitrosourea-induced sister chromatid exchanges in proliferating human lymphocytes. | 1989 | 24 |
| 8 | 1992 | 9 | |
| 9 | 1988 | 2 |
About Joan E. Trey
Joan E. Trey is a scholar working on Cancer Research, Otorhinolaryngology, Oncology, Emergency Medicine and Molecular Biology, having authored 9 papers that have together received 934 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (4 papers), Carcinogens and Genotoxicity Assessment (2 papers), Hematological disorders and diagnostics (1 paper), Gastric Cancer Management and Outcomes (1 paper), Head and Neck Cancer Studies (1 paper), Rheumatoid Arthritis Research and Therapies (1 paper), Genetic factors in colorectal cancer (1 paper) and Systemic Lupus Erythematosus Research (1 paper). The work is most often cited by research in Cancer Research (280 citations), Oncology (419 citations), Genetics (109 citations), Hematology (65 citations) and Molecular Biology (375 citations). Joan E. Trey has collaborated with scholars based in United States. Frequent co-authors include Stanton L. Gerson, Kathleen M. Miller, Nathan A. Berger, Irving Kushner, S L Gerson, James K. V. Willson, J R Haaga, T A Stellato, Nahida H. Gordon and John Hines. Their work appears in journals such as Critical Reviews in Oncology/Hematology, Cancer, Journal of Clinical Oncology, The Lancet Oncology and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.